Kuwait vs Lithuania: The number of people with susceptibility test result for rifampicin
Kuwait
401
in 2021
Lithuania
465
in 2021
Kuwait rank
85th
Lithuania rank
82nd
The number of people with susceptibility test result for rifampicin over time
- Kuwait
- Lithuania
How they compare
Lithuania currently reports 465 against 401 in Kuwait, a difference of 64.
That makes Lithuania's figure about 1.2 times Kuwait's.
Across all 5 years both countries report, Lithuania has been ahead every year.
Kuwait ranks 85th and Lithuania ranks 82nd of 155 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kuwait | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 346.33 | 777 | 430.67 | Lithuania |
| 2020s | 350 | 474 | 124 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kuwait or Lithuania?
- Lithuania, at 465 against 401 in Kuwait as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kuwait and Lithuania?
- 64, with Lithuania ahead.
- How many years of comparable data are there for Kuwait and Lithuania?
- 5 years are reported by both, from 2017 to 2021.
- How do Kuwait and Lithuania rank globally for the number of people with susceptibility test result for rifampicin?
- Kuwait ranks 85th and Lithuania ranks 82nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.